• Pyridostatin: A G-Quadruplex DNA Structure Stabilizer in Can

  2026-07-06

  Pyridostatin is a synthetic small molecule that selectively stabilizes G-quadruplex DNA structures, disrupting telomere function and inhibiting cancer cell growth. The compound exhibits preferential cytotoxicity for fibrosarcoma cells and has enabled new insights in telomere biology and protein aggregation research. Pyridostatin TFA is widely used in advanced workflows targeting DNA secondary structure dynamics.

• DrPISA: Expanding Proteomic Drug Target Discovery with DES-4

  2026-07-05

  DrPISA introduces a deep eutectic solvent-assisted reverse PISA workflow, markedly increasing the detection of heat-aggregated proteins and enhancing sensitivity in drug target identification. The study’s innovations broaden chemical proteomics by enabling access to previously overlooked insoluble proteome fractions, with direct implications for mechanistic studies involving compounds like puromycin aminonucleoside.

• Clathrin-Mediated Endocytosis in Grass Carp Reovirus Entry

  2026-07-04

  Wang et al. (2018) use a targeted pharmacological inhibitor analysis to clarify the cellular entry mechanism of type III grass carp reovirus (GCRV104), providing evidence that clathrin-mediated, pH-dependent endocytosis is essential for infection in cultured kidney cells. This mechanistic insight advances the antiviral research field by pinpointing key steps and potential therapeutic targets in GCRV cellular invasion.

• Tariquidar (XR9576): Next-Gen ABC Transporter Inhibition in

  2026-07-03

  Tariquidar (XR9576) delivers high-potency, selective P-glycoprotein inhibition, empowering researchers to dissect drug efflux mechanisms even in complex, high-viscosity tumor models. By integrating recent mechanobiology findings, advanced workflows, and troubleshooting strategies, Tariquidar from APExBIO sets the benchmark for cancer chemoresistance studies.

• BCL-XL Inhibitor A-1155463: Applied Cancer Research Workflow

  2026-07-03

  The selective BCL-XL inhibitor A-1155463 enables precise induction of apoptosis in drug-resistant cancer cell models, outperforming earlier tools in both potency and selectivity. This guide translates recent glioblastoma advances into practical workflows, troubleshooting, and comparative insight for hematological malignancies and solid tumor research.

• Copper-Coordinated Nanoplatform Elicits Cuproptosis for Mult

  2026-07-02

  This study introduces a baicalein–copper coordinated nanoassembly incorporating a boron-dipyrromethene photosensitizer for synergistic chemodynamic and photodynamic cancer therapy. The platform achieves enhanced bone penetration, targeted ROS generation, and cuproptosis induction, offering a promising strategy for treating primary and bone-metastatic tumors.

• STING Activation by PI4P and GNE-6468: Mechanistic Insights

  2026-07-02

  Han et al. reveal that the Golgi lipid PI4P and the chemical agonist GNE-6468 cooperatively activate the STING pathway through transmembrane helix rearrangement, defining a new mechanism for innate immune signaling. This structural and functional insight has broad relevance for developing targeted immunotherapies and screening anti-cancer agents that modulate the cGAS-STING axis.

• Astrocyte-Microglia Crosstalk via CSF1 and IFN-β in CNS Repa

  2026-07-01

  This study identifies a reciprocal signaling mechanism between astrocytes and microglia that is essential for effective spinal cord injury repair. By mapping the CSF1 and IFN-β feedback loop at the lesion border, the research advances our understanding of glial cell coordination and highlights molecular targets for improving neural regeneration.

• Trelagliptin Enhances Osteoblast Differentiation via RUNX2 U

  2026-07-01

  This article examines the novel finding that Trelagliptin, a DPP-4 inhibitor, promotes osteoblastic differentiation by increasing RUNX2 expression, with implications for osteoporosis management. The study employs in vitro models to elucidate AMPK-dependent mechanisms, offering new directions for bone biology research.

• BmTyr Click Chemistry Enables Biotin-Free Proteome Profiling

  2026-06-30

  This study introduces a biotin-free, click-compatible proximity labeling platform using engineered BmTyr tyrosinase for detailed subcellular proteome mapping in primary T cells. The method overcomes limitations of traditional biotin-based systems, providing improved specificity and sensitivity for studying protein interactions in challenging cell types.

• Acetylation-Dependent Spliceosome Regulation in HCC Therapy

  2026-06-30

  This study uncovers how acetylation of the spliceosome core protein SmD2 regulates alternative splicing and DNA damage response in hepatocellular carcinoma (HCC). The findings establish HDAC2-mediated deacetylation of SmD2 as a stabilizing mechanism and demonstrate that combining HDAC and PARP inhibition enhances therapeutic sensitivity in HCC models.

• Moxidectin: Beyond Anthelmintic Use to Antifungal Synergy

  2026-06-29

  Explore how Moxidectin, a macrocyclic lactone anthelmintic, is revolutionizing parasitic worm control and opening new avenues in antifungal research. This article delivers advanced insights into mechanisms, protocols, and translational bridges distinct from previous reviews.

• Shh, Fgf10, and Fgfr2 Regulate Distinct Urethral Development

  2026-06-29

  This study compares penile urethral and prepuce development in guinea pigs and mice, revealing that differential expression of Shh, Fgf10, and Fgfr2 explains key species differences in urethral groove and prepuce formation. The findings inform models of congenital malformations and have direct implications for developmental biology research.

• Applied Protocols for (-)-Epigallocatechin Gallate (EGCG) in

  2026-06-28

  (-)-Epigallocatechin gallate (EGCG) is a versatile, high-purity reagent for dissecting oxidative stress, antiviral mechanisms, and tumorigenesis. This guide translates recent neurodegeneration and cancer research into actionable workflows, troubleshooting steps, and protocol upgrades, with evidence-driven recommendations for using APExBIO's EGCG.

• Tariquidar (XR9576) Workflows for Mechanobiology-Driven Drug

  2026-06-27

  Tariquidar (XR9576) is the gold-standard tool for dissecting P-glycoprotein-driven chemoresistance in complex, high-viscosity tumor microenvironments. This guide translates recent mechanobiology advances into actionable workflows, protocol enhancements, and troubleshooting strategies for reliable transporter inhibition in drug resistance research.

446 records 12/30 page Previous Next First page 上5页 1112131415 下5页 Last page